Moderna, Eli Lilly and Apple Rise Premarket

By Peter Nurse 

Investing.com — Stocks in focus in premarket trade on Tuesday, December 15th. Please refresh for updates.

• Eli Lilly (NYSE:LLY) stock rose 2.1% after the drugmaker said it would buy Prevail Therapeutics (NASDAQ:PRVL), up 86%, in a deal valued at $1.04 billion, to expand its presence in gene therapy. It also raised its quarterly dividend by 15%.

• Moderna (NASDAQ:MRNA) stock rose 3.2% after the FDA said the biotech’s Covid-19 vaccine meets expectations for emergency use, a crucial step towards the drug being approved.

• Boeing (NYSE:BA) stock rose 0.8% despite the aircraft manufacturer’s quality inspectors finding production flaws in other parts of its 787 Dreamliner than the areas previously disclosed.

• Apple (NASDAQ:AAPL) stock rose 2% after Nikkei reported that the company plans to manufacture up to 96 million iPhones in the first half of 2021, a nearly 30% year-on-year increase.

• Amazon (NASDAQ:AMZN) stock rose 0.7% despite California Attorney General Xavier Becerra petitioning a court to force the e-commerce giant to comply with the state’s investigation into the company’s handling of the coronavirus pandemic. 

• Pinterest (NYSE:PINS) stock rose 0.4% after the social media firm agreed to pay $22.5 to settle claims of gender discrimination brought by its former chief operating officer.

• Twitter (NYSE:TWTR) stock fell 0.1% after Ireland’s data regulator fined the social media giant around $500,000 for a bug that made some private tweets public, in the first sanction against a U.S. firm under a new European Union data privacy system.

• Chewy (NYSE:CHWY) stock rose 0.7% after the WSJ reported that the pet-supply retailer plans to ramp up the number of products it offers to help boost orders.